Show simple item record

dc.contributor.authorFiala, Sarah
dc.contributor.authorBrown, Marc
dc.contributor.authorJones, Stuart A.
dc.date.accessioned2011-11-21T11:01:05Z
dc.date.available2011-11-21T11:01:05Z
dc.date.issued2011-11
dc.identifier.citationFiala , S , Brown , M & Jones , S A 2011 , ' Dynamic in-situ eutectic formation for topical drug delivery ' , Journal of Pharmacy and Pharmacology , vol. 63 , no. 11 , pp. 1428-1436 . https://doi.org/10.1111/j.2042-7158.2011.01346.x
dc.identifier.issn0022-3573
dc.identifier.urihttp://hdl.handle.net/2299/7029
dc.descriptionThe definitive version can be found at: http://onlinelibrary.wiley.com/ Copyright The Authors, JPP, Royal Pharmaceutical Society [Full text of this article is not available in the UHRA]
dc.description.abstractObjectives: The relationship between the solution-state chemistry of eutectic systems and their transmembrane transport characteristics is difficult to define as these mixtures are sensitive to delivery vehicle-induced penetration enhancement. Through in-situ formation of a molten eutectic mixture using highly evaporative sprays this study aimed to gain an understanding of solution-state thermodynamic and chemical properties of eutectic combinations pertinent to transmembrane transport in the absence of a delivery vehicle. Methods: In-situ molten lidocaine-prilocaine eutectics were formed using a hydroflouroalkane (HFA) propellant. Transport through silicone membranes and human skin in upright Franz diffusion cells was determined using in-house manufactured creams as controls. Key findings: The application of the two drugs in an HFA spray produced a molten oil even when the melting point of the drug mixture was above the experimental temperature at the membrane surface. In the absence of vehicle effects, molecule presentation to the membrane interface was most effective using a lidocaine-rich mixture of 0.7% w/w lidocaine: prilocaine -1985.06 +/- 128.87 mu g/h/cm(2). Conclusions: There appeared to be no link between melting point and transmembrane transport of lidocaine: prilocaine from a eutectic mixture. The rate of drug presentation to the membrane interface, which was highest in drug-rich, high-activity molten eutectic mixtures, was the driver for transmembrane transport in the absence of significant barrier interactions.en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofJournal of Pharmacy and Pharmacology
dc.subjecteutectic
dc.subjectlidocaine
dc.subjecto/w cream
dc.subjectprilocaine
dc.subjectspray
dc.titleDynamic in-situ eutectic formation for topical drug deliveryen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionToxicology
dc.contributor.institutionNanopharmaceutics
dc.contributor.institutionBioadhesive Drug Delivery Group
dc.contributor.institutionAirway Group
dc.contributor.institutionSkin and Nail Group
dc.contributor.institutionPharmaceutics
dc.contributor.institutionPharmaceutical Analysis and Product Characterisation
dc.contributor.institutionCentre for Research into Topical Drug Delivery and Toxicology
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1111/j.2042-7158.2011.01346.x
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record